Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.24) by 12.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $8.054 million which beat the analyst consensus estimate of $7.875 million by 2.27 percent. This is a 10.91 percent increase over sales of $7.262 million the same period last year.